ArticleOncoimmunology2020

Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies.

Jacobo Rogado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.